FDA.reportPublic FDA data

bacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG / pramoxine hydrochloride 0.01 MG/MG Topical Ointment

RxCUI
1359343
RxNorm name
bacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG / pramoxine hydrochloride 0.01 MG/MG Topical Ointment
Display name
Bacitracin/Neomycin/Polymyxin B/Pramoxine (Topical)
Full name
bacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG / pramoxine hydrochloride 0.01 MG/MG Topical Ointment
Term type
SCD
Status
Active
Strength
0.4-0.0035-10-0.01 var units
Dose form
Ointment
Route
Topical
Updated
2026-07-23 06:56:31

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
122012
Active start
122012
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
bacitracin zinc0.4 UNT / 1 MGbacitracinbacitracin
pramoxine hydrochloride0.01 MG / 1 MGpramoxinepramoxine hydrochloride
neomycin sulfate0.0035 MG / 1 MGneomycinneomycin
polymyxin B sulfate10 UNT / 1 MGpolymyxin Bpolymyxin B

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Topical Ointment316985

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
bacitracin1291
pramoxine34347
neomycin7299
polymyxin B8536

Source Vocabulary Codes#

Code type, Value, Category table
Code typeValueCategory
PRESCRIBABLEYATTRIBUTES
RXNAV_STRbacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG / pramoxine hydrochloride 0.01 MG/MG Topical OintmentNAMES
RxNorm Namebacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG / pramoxine hydrochloride 0.01 MG/MG Topical OintmentNAMES
RxNorm Synonymbacitracin 400 UNT / neomycin 3.5 MG / polymyxin B 10,000 UNT / pramoxine hydrochloride 10 MG per GM Topical OintmentNAMES
TTYSCDATTRIBUTES
RxCUI1359343CODES
MMSL_CODECD7007CODES

RxNav Current And Historical NDCs#

NDC11, Source, Active table
NDC11SourceActive
11509000340rxnav_historical_indirect
38137004512rxnav_historical_indirect
38137004513rxnav_historical_indirect
55499025910rxnav_historical_indirect
55499025915rxnav_historical_indirect

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCD04ABAnesthetics for topical useATC1-4pramoxine
ATCS01AAAntibioticsATC1-4bacitracin
ATCR02ABAntibioticsATC1-4bacitracin
ATCA07AAAntibioticsATC1-4neomycin
ATCA07AAAntibioticsATC1-4polymyxin B
ATCS01AAAntibioticsATC1-4neomycin
ATCR02ABAntibioticsATC1-4neomycin
ATCS01AAAntibioticsATC1-4polymyxin B
ATCS02AAAntiinfectivesATC1-4polymyxin B
ATCS03AAAntiinfectivesATC1-4polymyxin B
ATCB05CAAntiinfectivesATC1-4neomycin
ATCS03AAAntiinfectivesATC1-4neomycin
ATCS02AAAntiinfectivesATC1-4neomycin
ATCA01ABAntiinfectives and antiseptics for local oral treatmentATC1-4neomycin
ATCC05ADLocal anestheticsATC1-4pramoxine
ATCJ01GBOther aminoglycosidesATC1-4neomycin
ATCJ01XXOther antibacterialsATC1-4bacitracin
ATCD06AXOther antibiotics for topical useATC1-4bacitracin
ATCD06AXOther antibiotics for topical useATC1-4neomycin
ATCJ01XBPolymyxinsATC1-4polymyxin B
FDASPLD000617AminoglycosidesCHEMhas_chemical_structureneomycin
FDASPLN0000175477Aminoglycoside AntibacterialEPChas_epcneomycin
FDASPLN0000175499Polymyxin-class AntibacterialEPChas_epcpolymyxin B
FDASPLN0000008479Decreased Cell Wall Synthesis & RepairPEhas_pebacitracin
MEDRTD001414BacitracinCHEMhas_ingredientbacitracin
MEDRTD009025MorpholinesCHEMhas_ingredientpramoxine
MEDRTD009025MorpholinesCHEMhas_ingredientpramoxine hydrochloride
MEDRTD009355NeomycinCHEMhas_ingredientneomycin
MEDRTD011112Polymyxin BCHEMhas_ingredientpolymyxin B
MEDRTD016470BacteremiaDISEASEmay_treatpolymyxin B
MEDRTD001424Bacterial InfectionsDISEASEmay_preventneomycin
MEDRTD003877Dermatitis, ContactDISEASEmay_treatpramoxine
MEDRTD003877Dermatitis, ContactDISEASEmay_treatpramoxine hydrochloride
MEDRTD004342Drug HypersensitivityDISEASEci_withneomycin
MEDRTD004342Drug HypersensitivityDISEASEci_withpolymyxin B
MEDRTD004342Drug HypersensitivityDISEASEci_withbacitracin
MEDRTD004342Drug HypersensitivityDISEASEci_withpramoxine hydrochloride
MEDRTD004342Drug HypersensitivityDISEASEci_withpramoxine
MEDRTD004653EmpyemaDISEASEmay_treatbacitracin
MEDRTD004761Enterocolitis, PseudomembranousDISEASEmay_treatbacitracin
MEDRTD004927Escherichia coli InfectionsDISEASEmay_treatpolymyxin B
MEDRTD004927Escherichia coli InfectionsDISEASEmay_treatneomycin
MEDRTD015818Eye Infections, BacterialDISEASEmay_treatbacitracin
MEDRTD015818Eye Infections, BacterialDISEASEmay_treatpolymyxin B
MEDRTD005401Fissure in AnoDISEASEmay_treatpramoxine hydrochloride
MEDRTD005401Fissure in AnoDISEASEmay_treatpramoxine
MEDRTD005767Gastrointestinal DiseasesDISEASEmay_treatpolymyxin B
MEDRTD006192Haemophilus InfectionsDISEASEmay_treatpolymyxin B
MEDRTD006484HemorrhoidsDISEASEmay_treatpramoxine hydrochloride
MEDRTD006484HemorrhoidsDISEASEmay_treatpramoxine
MEDRTD006501Hepatic EncephalopathyDISEASEmay_treatneomycin
MEDRTD015212Inflammatory Bowel DiseasesDISEASEci_withneomycin
MEDRTD007415Intestinal ObstructionDISEASEci_withneomycin
MEDRTD007674Kidney DiseasesDISEASEci_withbacitracin
MEDRTD007710Klebsiella InfectionsDISEASEmay_treatpolymyxin B
MEDRTD016920Meningitis, BacterialDISEASEmay_treatpolymyxin B
MEDRTD010032Otitis ExternaDISEASEmay_treatpolymyxin B
MEDRTD010146PainDISEASEmay_treatpramoxine
MEDRTD010146PainDISEASEmay_treatpramoxine hydrochloride
MEDRTD011014PneumoniaDISEASEmay_treatbacitracin
MEDRTD011537PruritusDISEASEmay_treatpramoxine
MEDRTD011537PruritusDISEASEmay_treatpramoxine hydrochloride
MEDRTD011552Pseudomonas InfectionsDISEASEmay_treatpolymyxin B
MEDRTD012871Skin DiseasesDISEASEmay_treatpolymyxin B
MEDRTD017192Skin Diseases, BacterialDISEASEmay_treatbacitracin
MEDRTD017192Skin Diseases, BacterialDISEASEmay_preventbacitracin
MEDRTD017192Skin Diseases, BacterialDISEASEmay_treatneomycin
MEDRTD018461Soft Tissue InfectionsDISEASEmay_treatpolymyxin B
MEDRTD013203Staphylococcal InfectionsDISEASEmay_treatbacitracin
MEDRTD013290Streptococcal InfectionsDISEASEmay_treatbacitracin
MEDRTD001745Urinary Bladder DiseasesDISEASEmay_treatpolymyxin B
MEDRTD014947Wounds and InjuriesDISEASEmay_treatpolymyxin B
MEDRTN0000000226Acid-Base ActivityMOAhas_moapolymyxin B
MEDRTN0000009954Cell Membrane Fusion Complex InteractionsMOAhas_moabacitracin
MEDRTN0000000227Cholinergic Nicotinic AntagonistsMOAci_moapolymyxin B
MEDRTN0000000163Enzyme InteractionsMOAhas_moabacitracin
MEDRTN0000000150Protein Synthesis InhibitorsMOAhas_moaneomycin
MEDRTN0000009915Unknown Cellular or Molecular InteractionMOAhas_moapramoxine
MEDRTN0000009915Unknown Cellular or Molecular InteractionMOAhas_moapramoxine hydrochloride
MEDRTN0000008346Cellular Structure AlterationPEhas_pepolymyxin B
MEDRTN0000008479Decreased Cell Wall Synthesis & RepairPEhas_pebacitracin
MEDRTN0000008841Decreased Protein SynthesisPEhas_peneomycin
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pepramoxine
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pepramoxine hydrochloride
MEDRTN0000008953Decreased Striated Muscle ContractionPEci_pepolymyxin B

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.4 UNT/MG / 0.0035 MG/MG / 10 UNT/MG / 0.01 MG/MG
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESPRESCRIBABLEY
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
ATTRIBUTESTTYSCD
CODESMMSL_CODECD7007
CODESRxCUI1359343
NAMESPrescribable Synonymbacitracin 400 UNT / neomycin 3.5 MG / polymyxin B 10,000 UNT / pramoxine HCl 10 MG per GM Topical Ointment
NAMESRXNAV_STRbacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG / pramoxine hydrochloride 0.01 MG/MG Topical Ointment
NAMESRxNorm Namebacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG / pramoxine hydrochloride 0.01 MG/MG Topical Ointment
NAMESRxNorm Synonymbacitracin 400 UNT / neomycin 3.5 MG / polymyxin B 10,000 UNT / pramoxine hydrochloride 10 MG per GM Topical Ointment
SOURCESSourceMultum MediSource Lexicon